» Articles » PMID: 29496516

Magnetic Resonance Imaging and Spectroscopy Evidence of Efficacy for Adrenal and Gonadal Hormone Replacement Therapy in Anorexia Nervosa

Overview
Journal Bone
Date 2018 Mar 3
PMID 29496516
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Dehydroepiandrosterone (DHEA)+estrogen/progestin therapy for adolescent girls with anorexia nervosa (AN) has the potential to arrest bone loss. The primary aim of this study was to test the effects of DHEA+estrogen/progestin therapy in adolescent girls with AN on bone marrow in the distal femur using magnetic resonance imaging (MRI) and spectroscopy.

Methods: Seventy adolescent girls with AN were enrolled in a double blind, randomized, placebo-controlled trial at two urban hospital-based programs.

Intervention: Seventy-six girls were randomly assigned to receive 12months of either oral micronized DHEA or placebo. DHEA was administered with conjugated equine estrogens (0.3mg daily) for 3months, then an oral contraceptive (20μg ethinyl estradiol/ 0.1mg levonorgestrel) for 9months. The primary outcome measure was bone marrow fat by MRI and magnetic resonance spectroscopy (MRS).

Results: T2 of the water resonance dropped significantly less in the active vs. placebo group over 12months at both the medial and lateral distal femur (p=0.02). Body mass index (BMI) was a significant effect modifier for T1 and for T2 of unsaturated (T2) and saturated fat (T2) in the lateral distal femur. Positive effects of the treatment of DHEA+estrogen/progestin were seen primarily for girls above a BMI of about 18kg/m.

Conclusions: These findings suggest treatment with oral DHEA+estrogen/progestin arrests the age- and disease-related changes in marrow fat composition in the lateral distal femur reported previously in this population.

Citing Articles

Low-Magnitude Mechanical Signals to Preserve Skeletal Health in Female Adolescents With Anorexia Nervosa: A Randomized Clinical Trial.

DiVasta A, Stamoulis C, Rubin C, Sadler Gallagher J, Kiel D, Snyder B JAMA Netw Open. 2024; 7(10):e2441779.

PMID: 39480424 PMC: 11528308. DOI: 10.1001/jamanetworkopen.2024.41779.


Dehydroepiandrosterone and Its Metabolite 5-Androstenediol: New Therapeutic Targets and Possibilities for Clinical Application.

Fedotcheva T, Uspenskaya M, Ulchenko D, Shimanovsky N Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338348 PMC: 11435263. DOI: 10.3390/ph17091186.


Psychiatric and medical comorbidities of eating disorders: findings from a rapid review of the literature.

Hambleton A, Pepin G, Le A, Maloney D, Touyz S, Maguire S J Eat Disord. 2022; 10(1):132.

PMID: 36064606 PMC: 9442924. DOI: 10.1186/s40337-022-00654-2.


Bone density and bone marrow composition in transgender girls prior to pubertal blockade: A case series.

Guss C, Eiduson R, Vajapeyam S, Ecklund K, Mulkern R, Dahlberg S Bone. 2022; 162:116454.

PMID: 35667601 PMC: 9792193. DOI: 10.1016/j.bone.2022.116454.


Impact of Adrenal Hormone Supplementation on Bone Geometry in Growing Teens With Anorexia Nervosa.

DiVasta A, Feldman H, ODonnell J, Long J, Leonard M, Gordon C J Adolesc Health. 2019; 65(4):462-468.

PMID: 31227390 PMC: 7001735. DOI: 10.1016/j.jadohealth.2019.04.003.

References
1.
Patsch J, Li X, Baum T, Yap S, Karampinos D, Schwartz A . Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures. J Bone Miner Res. 2013; 28(8):1721-8. PMC: 3720702. DOI: 10.1002/jbmr.1950. View

2.
DiVasta A, Feldman H, Giancaterino C, Rosen C, LeBoff M, Gordon C . The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism. 2012; 61(7):1010-20. PMC: 3465078. DOI: 10.1016/j.metabol.2011.11.016. View

3.
Devlin M, Brooks D, Conlon C, van Vliet M, Louis L, Rosen C . Daily leptin blunts marrow fat but does not impact bone mass in calorie-restricted mice. J Endocrinol. 2016; 229(3):295-306. PMC: 5171226. DOI: 10.1530/JOE-15-0473. View

4.
Hess R, Pino A, Rios S, Fernandez M, Rodriguez J . High affinity leptin receptors are present in human mesenchymal stem cells (MSCs) derived from control and osteoporotic donors. J Cell Biochem. 2004; 94(1):50-7. DOI: 10.1002/jcb.20330. View

5.
Gimble J, Zvonic S, Floyd Z, Kassem M, Nuttall M . Playing with bone and fat. J Cell Biochem. 2006; 98(2):251-66. DOI: 10.1002/jcb.20777. View